Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe

Author： Fleischhacker Wolfgang   Burns Tom    

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.162, Iss.1, 2002-06, pp. : 82-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Alternatives to placebo-controlled trials in psychiatry

By Montgomery S.A.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 265-269

Elsevier

Access to resources Recommend Favorite

Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline: A Pooled Analysis

By Tonstad Serena  

Drug Safety, Vol. 33, Iss. 4, 2010-04 ,pp. : 289-301

Adis International

Access to resources Recommend Favorite

Dose–response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder

By Bech Per   Kajdasz Daniel   Porsdal Vibeke  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 273-280

Springer Publishing Company

Access to resources Recommend Favorite

Placebo-controlled trials justified, says ethics group

By  

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Placebo-controlled trials no longer deemed ethical

By  

Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite